These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35993046)

  • 1. The Effect of Osteoprotectin (OPG)/Receptor Activator of Nuclear Factor-
    Luo W; Song Y; Wang J; Yang X; Li Z; Cong H
    Biomed Res Int; 2022; 2022():1592576. PubMed ID: 35993046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of osteoprotegerin and soluble ligand of receptor of kappa-B transcription factor activator in the calcification of aortic valve].
    Voronkina IV; Irtyuga OB; Smagina LV; Adamova PE; Zhiduleva EV; Malashicheva AB; Sibagatullina YS; Kruk LP; Gordeev ML; Moiseeva OM
    Biomed Khim; 2019 Jan; 65(1):57-62. PubMed ID: 30816098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
    Kaden JJ; Bickelhaupt S; Grobholz R; Haase KK; Sarikoç A; Kiliç R; Brueckmann M; Lang S; Zahn I; Vahl C; Hagl S; Dempfle CE; Borggrefe M
    J Mol Cell Cardiol; 2004 Jan; 36(1):57-66. PubMed ID: 14734048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J; Wang K; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
    Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
    Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
    Carrillo-López N; Martínez-Arias L; Alonso-Montes C; Martín-Carro B; Martín-Vírgala J; Ruiz-Ortega M; Fernández-Martín JL; Dusso AS; Rodriguez-García M; Naves-Díaz M; Cannata-Andía JB; Panizo S
    Nephrol Dial Transplant; 2021 Mar; 36(4):618-631. PubMed ID: 33367746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Ohashi R; Umezu H; Ajioka Y; Endo N
    Tohoku J Exp Med; 2019 Jun; 248(2):87-97. PubMed ID: 31189751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Values of osteoprotegerin in aortic valve tissue in patients with significant aortic stenosis depend on the existence of concomitant coronary artery disease.
    Fojt R; Pirk J; Kamenický P; Karpíšek M; Straka Z; Malý M; Moťovská Z
    Cardiovasc Pathol; 2016; 25(3):181-184. PubMed ID: 26874038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
    Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation.
    Liao C; Hua Y
    Arch Oral Biol; 2013 Dec; 58(12):1784-90. PubMed ID: 24200305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone-regulatory proteins in human valve allografts.
    Shetty R; Pepin A; Charest A; Perron J; Doyle D; Voisine P; Dagenais F; Pibarot P; Mathieu P
    Heart; 2006 Sep; 92(9):1303-8. PubMed ID: 16449517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.
    Shimamura M; Nakagami H; Osako MK; Kurinami H; Koriyama H; Zhengda P; Tomioka H; Tenma A; Wakayama K; Morishita R
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8191-6. PubMed ID: 24847069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of technetium-99 conjugated with methylene diphosphonate (
    Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
    J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension.
    Yang J; Si D; Zhao Y; He C; Yang P
    Biomed Pharmacother; 2019 Jun; 114():108799. PubMed ID: 30951948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease.
    Christoph F; König F; Lebentrau S; Jandrig B; Krause H; Strenziok R; Schostak M
    World J Urol; 2018 Feb; 36(2):187-192. PubMed ID: 29204705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.